Adverum Biotechnologies, Inc.
Symbole: ADVM
NASDAQ
10.43
USDPrix du marché aujourd'hui
-0.9010
Ratio P/E
0.0140
Ratio PEG
216.47M
Cap MRK
- 0.00%
Rendement DIV
Adverum Biotechnologies, Inc. (ADVM) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 519.35 | 96.5 | 185.6 | 305.2 | ||||||||||||
balance-sheet.row.short-term-investments | 160.24 | 21.5 | 117.2 | 271 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 5.7 | ||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-current-assets | 24.04 | 6.2 | 5 | 6.2 | ||||||||||||
balance-sheet.row.total-current-assets | 543.38 | 102.8 | 190.6 | 317.1 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 328.46 | 67 | 113.9 | 119.1 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-investments | 9.78 | 2 | 2.5 | 3.3 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 5.16 | 1.2 | 1.4 | 0.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 343.4 | 70.2 | 117.8 | 122.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 886.79 | 173 | 308.4 | 439.7 | ||||||||||||
balance-sheet.row.account-payables | 8.37 | 1.9 | 2.2 | 1.4 | ||||||||||||
balance-sheet.row.short-term-debt | 72.39 | 10.4 | 13.2 | 1.9 | ||||||||||||
balance-sheet.row.tax-payables | 0.54 | 0.1 | 0.3 | 1.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 266.93 | 64.6 | 93.6 | 101.1 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 33.49 | 12.5 | 16.8 | 2 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 266.93 | 64.6 | 94.6 | 102.2 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 328.92 | 64.6 | 106.8 | 103 | ||||||||||||
balance-sheet.row.total-liab | 411.69 | 89.5 | 126.9 | 123.5 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0.04 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.retained-earnings | -3510.69 | -919.8 | -802.6 | -648.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -2.43 | -0.5 | -1.5 | -0.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3988.17 | 1003.7 | 985.7 | 965 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 475.1 | 83.5 | 181.5 | 316.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 886.79 | 173 | 308.4 | 439.7 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 475.1 | 83.5 | 181.5 | 316.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 886.79 | - | - | - | ||||||||||||
Total Investments | 162.22 | 23.5 | 117.2 | 271 | ||||||||||||
balance-sheet.row.total-debt | 339.32 | 75 | 106.8 | 103 | ||||||||||||
balance-sheet.row.net-debt | -19.78 | 0 | 38.4 | 68.8 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -117.17 | -117.2 | -154.5 | -145.5 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 5.64 | 5.6 | 6.5 | 4.6 | ||||||||||||
cash-flows.row.deferred-income-tax | -7.26 | 0.4 | 0 | 3.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 17.57 | 17.6 | 20.1 | 25.2 | ||||||||||||
cash-flows.row.change-in-working-capital | -8.32 | -8.3 | 19.9 | 4.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.account-payables | -0.37 | -0.4 | 0.8 | -1.6 | ||||||||||||
cash-flows.row.other-working-capital | -7.95 | -7.9 | 19 | 5.7 | ||||||||||||
cash-flows.row.other-non-cash-items | 18.55 | 10.6 | -0.1 | 0 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -90.98 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.81 | -0.8 | -11.8 | -15.1 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.purchases-of-investments | -36.72 | -36.7 | -104.4 | -407.5 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 134.4 | 134.4 | 257.9 | 501.3 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 96.88 | 96.9 | 141.7 | 78.7 | ||||||||||||
cash-flows.row.debt-repayment | -2.34 | 0 | -13.6 | -0.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0.49 | 0.5 | 0 | 1.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 1.06 | -0.4 | 14.2 | 1 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.72 | 0.5 | 0.6 | 2.4 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.54 | 0.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 6.72 | 6.6 | 34.2 | -26.7 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 366.91 | 75 | 70.9 | 36.7 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 360.19 | 68.4 | 36.7 | 63.4 | ||||||||||||
cash-flows.row.operating-cash-flow | -90.98 | -91.3 | -108.1 | -107.8 | ||||||||||||
cash-flows.row.capital-expenditure | -0.81 | -0.8 | -11.8 | -15.1 | ||||||||||||
cash-flows.row.free-cash-flow | -91.79 | -92.1 | -119.9 | -123 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3.6 | 3.6 | 0 | 7.5 | ||||||||||||
income-statement-row.row.cost-of-revenue | 12.58 | 5.6 | 6.5 | 4.6 | ||||||||||||
income-statement-row.row.gross-profit | -8.98 | -2 | -6.5 | 2.9 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 77.48 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 49.91 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.01 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 5.75 | 5.7 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.operating-expenses | 126.38 | 121.7 | 157.1 | 153.6 | ||||||||||||
income-statement-row.row.cost-and-expenses | 127.39 | 127.4 | 157.1 | 153.6 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.interest-expense | -1.2 | 0 | -2.7 | 0 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.01 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 5.55 | 5.5 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 5.75 | 5.7 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.total-operating-expenses | 5.55 | 5.5 | 2.7 | 0.6 | ||||||||||||
income-statement-row.row.interest-expense | -1.2 | 0 | -2.7 | 0 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 5.64 | 5.6 | 6.5 | 4.6 | ||||||||||||
income-statement-row.row.ebitda-caps | -118.15 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -123.79 | -123.8 | -157.1 | -146.1 | ||||||||||||
income-statement-row.row.income-before-tax | -118.24 | -118.2 | -154.5 | -145.5 | ||||||||||||
income-statement-row.row.income-tax-expense | -1.08 | -1.1 | 0.1 | 0 | ||||||||||||
income-statement-row.row.net-income | -117.17 | -117.2 | -154.5 | -145.5 |
Questions fréquemment posées
Quel est le total de Adverum Biotechnologies, Inc. (ADVM) de l'actif total?
Adverum Biotechnologies, Inc. (ADVM) Le total des actifs est 173010000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est -2.494.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -9.069.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -32.546.
Quel est le revenu total de l'entreprise?
Le revenu total est -34.386.
Qu'est-ce que Adverum Biotechnologies, Inc. (ADVM) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -117165000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 75036000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 121747000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 75000000.000.